HOME >> MEDICINE >> NEWS
Trial reveals safer and simpler approach to treating children with cystic fibrosis

Treating chest infections in young cystic fibrosis patients with an antibiotic once instead of three times daily is as effective and less toxic, conclude the results of a randomised trial published in this week's issue of THE LANCET.

Aminoglycoside antibiotics are widely used for the management of patients who have cystic fibrosis and chronic chest infection with a bacterium called Pseudomonas aerginosa. Currently patients are given aminoglycosides three times daily. The drugs can cause damage to kidney function and hearing loss.

Alan Smyth (University of Nottingham, UK) and colleagues recruited 219 cystic fibrosis patients (125 children and 94 adults) between 1999 and 2003 in the UK. The patients were randomly assigned to receive an aminoglycoside called tobramycin intravenously once or three times daily for 14 days. The researchers measured changes in lung function and found that the two treatments had a similar effect. However in children, the once daily treatment caused fewer kidney related side effects.

Dr Alan Smyth comments: "Our results are likely to affect aminoglycoside prescription in cystic fibrosis in clinical practice. Once daily treatment may be preferred by patients receiving intravenous antibiotics because of its convenience. Antipseudomonal antibiotics are usually given as combinations of two or more drugs in cystic fibrosis because of concerns of emerging antibiotic resistance. Most other antipseudomonal antibiotics need to be given three times daily and so further development of other once daily antibiotics would be useful."

In an accompanying commentary Heather VandenBussche (Bronson Methodist Hospital, Michigan, USA) and Michael Klepser (Ferris State University College of Pharmacy, Michigan, USA) write that several unanswered questions persist about once daily aminoglycoside dosing in cystic fibrosis patients.

Dr VandenBussche concludes: " Smyth and colleagues' report provides some useful insights into
'"/>

Contact: Joe Santangelo
j.santangelo@elsevier.com
1-212-633-3810
Lancet
10-Feb-2005


Page: 1 2

Related medicine news :

1. Trials launched to test treatment of cognitive dysfunction in schizophrenia
2. Randomisation phase of the DIRECT programme (DIabetic REtinopathy Candesartan Trials) completed
3. Trials on hormone therapy and hypertension treatment change practice, medication usage of patients
4. Trial results have dramatically reduced HRT use
5. Release of results of Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial
6. Trial opens new possibilities for improving survival with a novel heart attack drug
7. Clinical Trials Litigation: Legal & Ethical Issues in Human Subjects Research
8. National Lung Screening Trial
9. New awards, expanded focus for Pediatric AIDS Clinical Trials Group
10. AAPS Workshop to Examine Chemistry and Manufacturing Controls Trials, Emerging Products
11. Abgenix Reports Positive Survival Data From A Phase II Trial Of ABX-CBL In Graft Versus Host Disease

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/16/2019)... ... May 16, 2019 , ... ... to market a patent pending, affordable, effective, easy-to-use, university-validated Platelet Rich Fibrin (PRF) ... latest achievement is a testament to the dedication of the Enso Discoveries team ...
(Date:5/15/2019)... ... 15, 2019 , ... There are only a handful of therapists in Los ... The Ed Asner Family Center to change that. , Officials with ... closely with the staff at The Ed Asner Family Center to train therapists who ...
(Date:5/15/2019)... ... 2019 , ... The American Academy of Thermology ... healthcare training and clinical application of medical infrared imaging, has announced the full ... will take place on September 7-8, 2019 at the Emory University Conference Center ...
(Date:5/14/2019)... ... , ... LIONS Clubs from Maryland, Virginia, Delaware and the District of Columbia ... National Memorial Day Parade. Local Lion’s Club Banners will denote the name of the ... in 1917, and will be celebrating our 102nd Anniversary this year. The float ...
(Date:5/14/2019)... ... May 14, 2019 , ... Kwalu announced today ... member-driven health care performance improvement company in the country. The contract was awarded ... experts from one of Vizient’s member-led councils. , Kwalu’s award-winning, wellness-focused, solid ...
Breaking Medicine News(10 mins):
(Date:5/14/2019)... ... May 14, 2019 , ... An April 30 article ... procedures. The long-held misconception is that the procedure is more than a little bit ... different decades and centuries prior, the article notes that “the majority of people that ...
(Date:5/14/2019)... ... May 14, 2019 , ... ... and technology services and solutions, specifically for Community Health Centers, recently announced ... suite of network support and cybersecurity service offerings. These collaborative services ...
(Date:5/14/2019)... ... May 14, 2019 , ... Concerto HealthAI, a next-generation integrated ... will present research findings based on an AI model that can correctly identify ... traditional business rules in a poster at the International Society for Pharmacoeconomics and ...
Breaking Medicine Technology:
Cached News: